Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Robert Nelsen
AddedMar 31, 2024
UpdatedJun 28, 2026
Robert Nelsen

Robert Nelsen

Co-Founder, Arch Venture Partners

Crunchbase

Robert Nelsen's Career

Arch Venture Partners
Arch Venture Partners

Chicago, IL, US

Co-Founder
NeurogesX
NeurogesX

San Mateo, CA, US

Board Member· Board
Denali Therapeutics
Denali Therapeutics

San Francisco, CA, US

Board Member· Board
Vir Biotechnology
Vir Biotechnology

San Francisco, CA, US

Board Member· Board
Beam Therapeutics
Beam Therapeutics

Cambridge, MA, US

Board Member· Board
Wisdo
Wisdo

New York City, NY, US

Board Member· Board
Ensemble Discovery
Ensemble Discovery

Cambridge, MA, US

Board Member· Board
Arivale
Arivale

Seattle, WA, US

Board Member· Board
Insitro
Insitro

South San Francisco, CA, US

Board Member· Board
Resilience
Resilience

Los Angeles, CA, US

Board Member· Board
Maze Therapeutics
Maze Therapeutics

South San Francisco, CA, US

Board Member· Board
GRAIL
GRAIL

Menlo Park, CA, US

Board Member· Board
Sapphire Energy
Sapphire Energy

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Robert Nelsen's Career

Arch Venture Partners
Arch Venture Partners
Investment FirmInvestment Firm671986Chicago, IL, US
Co-Founder

Recent news

Oratomic raises $300M to build a viable quantum computer that needs only 20K qubitsTechCrunch · 2026

Leadership at Arch Venture Partners

Keith CrandellKeith CrandellCo-Founder
Clinton BybeeClinton BybeeCo-Founder
Steve LazarusSteve LazarusCo-Founder

Similar to Arch Venture Partners

Atlas VentureAtlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29
Archer Venture CapitalArcher Venture CapitalLos Angeles, CA, USest. 2010Archer Venture CapitalLos Angeles, CA, US · est. 2010

Archer Venture Capital: An investment and advisory firm for start-ups and entrepreneurs.

Investment Firm8
Arch Development PartnersArch Development PartnersChicago, IL, USest. 2001Arch Development PartnersChicago, IL, US · est. 2001

ARCH Development Partners, L.L.C. is a US-based venture capital firm serving various clients.

Investment Firm30
Archetype VenturesArchetype Venturesward area of Tokyo, Tokyo, JPest. 2013Archetype Venturesward area of Tokyo, Tokyo, JP · est. 2013

Archetype Ventures: A venture capital firm specializing in seed and early-stage B2B investments, with a focus on the domestic internet industry.

Investment Firm33
NeurogesX
NeurogesX
Public$135.4M352007San Mateo, CA, US
Board Member· Board

Leadership at NeurogesX

Brett RobertsonBrett RobertsonCo-Founder
Wendye RobbinsWendye RobbinsCo-Founder
Denali Therapeutics
Denali Therapeutics

San Francisco, CA, US

Board Member· Board
Vir Biotechnology
Vir Biotechnology

San Francisco, CA, US

Board Member· Board
Beam Therapeutics
Beam Therapeutics
Public$689M5072017Cambridge, MA, US
Board Member· Board

Leadership at Beam Therapeutics

David R. LiuDavid R. LiuCo-Founder
Graham CooperGraham CooperBoard Member
John EvansJohn EvansBoard Member
J. Keith JoungJ. Keith JoungCo-Founder
Feng ZhangFeng ZhangCo-Founder
John EvansJohn EvansCEO
Wisdo
Wisdo

New York City, NY, US

Board Member· Board
Ensemble Discovery
Ensemble Discovery
Series B$30M132002Cambridge, MA, US
Board Member· Board

Leadership at Ensemble Discovery

David LiuDavid LiuCo-Founder
Doug ColeDoug ColeBoard Member
Arivale
Arivale
Series C$52.6M752014Seattle, WA, US
Board Member· Board

Recent news

Accel and Prosus team up to back early-stage Indian startupsTechCrunch · 2025

Leadership at Arivale

Clayton LewisClayton LewisBoard Member
Dan LevitanDan LevitanBoard Member
Nathan PriceNathan PriceCo-Founder
Leroy HoodLeroy HoodCo-Founder
Insitro
Insitro
Series C$643M2952018South San Francisco, CA, US
Board Member· Board

Leadership at Insitro

Vijay PandeVijay PandeBoard Member
Roger PerlmutterRoger PerlmutterBoard Member
Daphne KollerDaphne KollerCEO
Daphne KollerDaphne KollerCEO
Paul McCrackenPaul McCrackenBoard Member
Resilience
Resilience
Late Stage Private$2.5B2k2020Los Angeles, CA, US
Board Member· Board

Leadership at Resilience

Rahul SinghviRahul SinghviCEO
Raj ShahRaj ShahBoard Member
Bob KerreyBob KerreyBoard Member
Frances ArnoldFrances ArnoldBoard Member
Sue Desmond-HellmannSue Desmond-HellmannBoard Member
George BarrettGeorge BarrettBoard Member
Maze Therapeutics
Maze Therapeutics
Late Stage Private$381M1352018South San Francisco, CA, US
Board Member· Board

Leadership at Maze Therapeutics

Catherine SohnCatherine SohnBoard Member
Jason ColomaJason ColomaBoard Member
Richard SchellerRichard SchellerBoard Member
Andy TranAndy TranBoard Member
Jeffrey TongJeffrey TongBoard Member
Dan SpiegelmanDan SpiegelmanBoard Member

Similar to Maze Therapeutics

Mahzi TherapeuticsMahzi TherapeuticsSan Mateo, CA, USBiotechest. 2020Mahzi TherapeuticsSan Mateo, CA, US · est. 2020

Mahzi Therapeutics: A California-based healthcare and biotech firm, founded in 2020.

Series A · $47.3M13
Encoded TherapeuticsEncoded TherapeuticsSouth San Francisco, CA, USPrecision Therapiesest. 2014Encoded TherapeuticsSouth San Francisco, CA, US · est. 2014

Encoded: Leveraging human genome power for effective precision therapies in genetic disorders.

Series D · $239.1M200
Moma TherapeuticsMoma TherapeuticsCambridge, MA, USPrecision Medicinesest. 2020Moma TherapeuticsCambridge, MA, US · est. 2020

MOMA Therapeutics, a biotech firm, is dedicated to discovering precision medicines by unlocking molecular complexities.

Series B · $236M75
GRAIL
GRAIL
Public$2B8232016Menlo Park, CA, US
Board Member· Board

Recent news

Littlebird raises $11M for its AI-assisted ‘recall’ tool that reads your computer screenTechCrunch · 2026

Leadership at GRAIL

Mostafa RonaghiMostafa RonaghiBoard Member
Brook ByersBrook ByersBoard Member
Jeff DeanJeff DeanBoard Member
Jeff HuberJeff HuberBoard Member
Bob RagusaBob RagusaCEO
William H. RastetterWilliam H. RastetterBoard Member

Similar to GRAIL

FreenomeFreenomeSouth San Francisco, CA, USCancer Detectionest. 2014FreenomeSouth San Francisco, CA, US · est. 2014

Freenome, a US-based company, is dedicated to providing tools for cancer detection, treatment, and prevention.

Late Stage Private · $1.1B375
Guardant HealthGuardant HealthPalo Alto, CA, USCancer Diagnosticsest. 2011Guardant HealthPalo Alto, CA, US · est. 2011

Guardant Health: A Palo Alto-based biotech firm providing global cancer diagnostics and sequencing services.

Public1.8k
Thrive Earlier DetectionThrive Earlier DetectionCambridge, MA, USCancer Detectionest. 2019Thrive Earlier DetectionCambridge, MA, US · est. 2019

Thrive, a healthcare company, pioneers in early cancer detection through its innovative test, CancerSEEK.

Late Stage Private · $367M175
Sapphire Energy
Sapphire Energy
Private Equity$376.5M1502007San Diego, CA, US
Board Member· Board

Leadership at Sapphire Energy

Robert ShapiroRobert ShapiroBoard Member
Nathaniel DavidNathaniel DavidFounder
Steve GoldbySteve GoldbyBoard Member
Cynthia WarnerCynthia WarnerCEO
Kristina BurowKristina BurowBoard Member

Similar to Sapphire Energy

Sapphire TechnologiesSapphire TechnologiesCerritos, CA, USEnergy Recovery Systemsest. 2021Sapphire TechnologiesCerritos, CA, US · est. 2021

Sapphire Technologies: Leading manufacturer of energy recovery systems for gas and hydrogen applications.

Series B · $10M23
Renewable Fuel ProductsRenewable Fuel ProductsSan Francisco, CA, USBiomass, Renewable Energyest. 2007Renewable Fuel ProductsSan Francisco, CA, US · est. 2007

Renewable Fuel Products, Inc: A startup pioneering in renewable energy alternatives and algae biomass systems.

Seed · $145k1
Bloom EnergyBloom EnergySan Jose, CA, USFuel Cells, Hydrogenest. 2001Bloom EnergySan Jose, CA, US · est. 2001

Bloom Energy: A San Jose-based energy firm providing low-emission electricity and hydrogen through solid-oxide fuel cells globally.

Public2.5k

Robert Nelsen's Co-Investors

Rande GerberRande GerberCo-invested · Katalyst Series ACindy CrawfordCindy CrawfordCo-invested · Katalyst Series AParis HiltonParis HiltonCo-invested · Colossal Biosciences Series ACharles HoskinsonCharles HoskinsonCo-invested · Colossal Biosciences Series AMilad AlucozaiMilad AlucozaiCo-invested · Colossal Biosciences Series AThomas TullThomas TullCo-invested · Colossal Biosciences Series AAnne WojcickiAnne WojcickiCo-invested · Gameto Series AKen HoweryKen HoweryCo-invested · Neuralink Series C

Robert Nelsen's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Robert Nelsen

Eric PepinEric PepinCo-Founder · ResiliantSteven RosenSteven RosenCo-Founder · Resilience Capital PartnersBill ReidBill ReidBoard Member · DreamitRyan PleskachRyan PleskachCo-Founder · ResilienXMichael LevinthalMichael LevinthalCo-Founder · Onset Ventures